Skip to content
value.today

Maxigen Biotech Inc. vs Stereotaxis, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Stereotaxis, Inc. is the larger company by market value: $92 M against $87 M for Maxigen Biotech Inc., 1.1 times as much (market caps of Nov 20, 2026 for Maxigen Biotech Inc. and Oct 30, 2026 for Stereotaxis, Inc.).

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0751502253002020202120222023202420252026Maxigen Biotech Inc. 150Stereotaxis, Inc. 27

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Stereotaxis, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureMaxigen Biotech Inc.
1783.TW · #19,241 in the world
Stereotaxis, Inc.
STXS · #19,021 in the world
Profile
Country🇹🇼 Taiwan🇺🇸 USA
SectorHealthcareHealthcare
IndustryMedical InstrumentsMedical Instruments
Founded—1990
Size
Market cap$87 M$92 M
Revenue—$32 M
Net income—$-22 M
Employees—131
Valuation
Price to sales—2.9×
Price to book—6.8×
Free cash flow yield—-15.0%
Profitability
Gross margin—52.7%
Operating margin—-68.3%
Net margin—-66.8%
Return on equity—-221.3%
Growth
Revenue growth—20.3%
Revenue growth, 3 years a year—4.8%
Cash
Free cash flow margin—-42.5%
Shareholder returns
Dividend yield—0.0%
Shareholder yield—0.0%
Altman Z-score zone—distress
Data as ofMarket cap Nov 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Maxigen Biotech Inc. or Stereotaxis, Inc.?

Stereotaxis, Inc. is the larger company by market value: $92 M against $87 M for Maxigen Biotech Inc., 1.1 times as much (market caps of Nov 20, 2026 for Maxigen Biotech Inc. and Oct 30, 2026 for Stereotaxis, Inc.).